AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ANIMALCARE GROUP PLC

Board/Management Information Feb 10, 2022

7488_rns_2022-02-10_c44b0cc2-ad7f-4bb5-8085-184523d081bf.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3425B

Animalcare Group PLC

10 February 2022

ANIMALCARE GROUP PLC

(the "Company" or the "Group")

Appointment of Non-Executive Director

10 February 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, today announces the appointment of Dr Douglas Hutchens to its Board of Directors as an Independent Non-Executive Director with immediate effect.

Douglas Hutchens has held several senior positions in research and development (R&D) and regulatory affairs at leading global animal health companies. As part of the executive team at Bayer Animal Health, he was an Executive Vice President and Chief Veterinary Officer where he led both drug discovery and product development on a global basis. More recently, he has held positions on several R&D advisory boards.

Before joining the animal health pharmaceutical industry, Douglas was an Assistant Professor at the University of Illinois College of Veterinary Medicine. There, he conducted studies for most of the major animal health companies and participated in the development of multiple new products for companion and production animals. Early in his career he was a practicing veterinarian. Douglas holds a Doctor of Veterinary Medicine degree and a PhD in pathobiology with an emphasis in immuno-parasitology from the University of Illinois.

Jan Boone, Chairman of Animalcare Group plc, said: "We are delighted to welcome Douglas to the Animalcare Group Board. Douglas brings a wealth of expertise in veterinary medicine and R&D from leadership roles at some of the world's biggest animal health companies. His knowledge and extensive network will prove invaluable as we pursue our long-term growth strategy."

Additional Information

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Douglas Eugene Hutchens, aged 58:

Current Directorships Previous Directorships
None Bayer Animal Health GmbH

As of the date of this announcement, Dr Hutchens holds no ordinary shares in the capital of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

Enquiries

Animalcare Group plc

Jenny Winter, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Media/investor relations
+44 (0)1904 487 687

[email protected]
Stifel Nicolaus Europe Limited

(Nominated Adviser & Joint Broker)

Ben Maddison

Fred Walsh

Nicholas Harland

Nick Adams
+44 (0)20 7710 7600
Panmure Gordon

(Joint Broker)

Corporate Finance

Freddy Crossley/Emma Earl

Corporate Broking

Rupert Dearden
+44 (0)20 7886 2500

About Animalcare

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

For more information about Animalcare, please visit www.animalcaregroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOADZGMZDGDGZZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.